Clinical trials recruiting for Non-small Cell Lung Cancer Stage III

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)
  NCT07640789 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
  NCT06908070 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
  NCT02622581 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
  NCT05398094 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
  NCT06463665 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• HEARTS Trial for Thoracic Cancers
  NCT07132918 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
  NCT06449313 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer
  NCT04728724 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
  NCT07104630 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
  NCT05557552 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Non-small Cell Lung Cancer Stage III often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Non-small Cell Lung Cancer Stage III trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.